Compare MSD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSD | TMCI |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.4M | 174.6M |
| IPO Year | N/A | 2021 |
| Metric | MSD | TMCI |
|---|---|---|
| Price | $7.30 | $2.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.87 |
| AVG Volume (30 Days) | 70.2K | ★ 777.8K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 11.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $218,879,000.00 |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | N/A | $1.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $6.11 | $2.44 |
| 52 Week High | $7.46 | $10.79 |
| Indicator | MSD | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 25.73 |
| Support Level | $7.35 | $2.44 |
| Resistance Level | $7.46 | $2.76 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 0.29 | 4.81 |
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.